184 related articles for article (PubMed ID: 30645828)
1. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
[TBL] [Abstract][Full Text] [Related]
2. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
[TBL] [Abstract][Full Text] [Related]
3. Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone.
Yüksel K; Tuğlular I
Int J Clin Pharm; 2019 Apr; 41(2):387-390. PubMed ID: 30864085
[TBL] [Abstract][Full Text] [Related]
4. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
Chen HL; Hsiao FY
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):841-8. PubMed ID: 26098410
[TBL] [Abstract][Full Text] [Related]
5. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
Leelakanok N; Holcombe A; Schweizer ML
Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
[TBL] [Abstract][Full Text] [Related]
6. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
Ou LB; Moriello C; Douros A; Filion KB
Br J Clin Pharmacol; 2021 Oct; 87(10):3649-3658. PubMed ID: 33439512
[TBL] [Abstract][Full Text] [Related]
7. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
Buffery PJ; Strother RM
N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
[TBL] [Abstract][Full Text] [Related]
8. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
Rochoy M; Auffret M; Béné J; Gautier S;
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
[TBL] [Abstract][Full Text] [Related]
10. Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France.
Hill C; Nicot P; Piette C; Le Gleut K; Durand G; Toussaint B
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):543-7. PubMed ID: 25832309
[TBL] [Abstract][Full Text] [Related]
11. [Domperidone and the risk of sudden cardiac death].
van Roeden SE; Belle-van Meerkerk G; van Tuyl SA; van de Ree MA; Muller AF
Ned Tijdschr Geneeskd; 2013; 157(45):A6770. PubMed ID: 24191928
[TBL] [Abstract][Full Text] [Related]
12. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
[No Abstract] [Full Text] [Related]
13. Domperidone: ventricular arrhythmia and sudden death (continued).
Prescrire Int; 2012 Jul; 21(129):183. PubMed ID: 22852288
[TBL] [Abstract][Full Text] [Related]
14. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
Renoux C; Dell'Aniello S; Khairy P; Marras C; Bugden S; Turin TC; Blais L; Tamim H; Evans C; Steele R; Dormuth C; Ernst P;
Br J Clin Pharmacol; 2016 Aug; 82(2):461-72. PubMed ID: 27062307
[TBL] [Abstract][Full Text] [Related]
15. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
[TBL] [Abstract][Full Text] [Related]
16. Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China.
Zhang Y; Shu M; Liang W; Jiang K; Zhang D; Qiu H; Wu K
Adv Ther; 2020 Apr; 37(4):1564-1578. PubMed ID: 32146705
[TBL] [Abstract][Full Text] [Related]
17. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
Johannes CB; Varas-Lorenzo C; McQuay LJ; Midkiff KD; Fife D
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):881-8. PubMed ID: 20652862
[TBL] [Abstract][Full Text] [Related]
18. Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
Forbes N; Cooray M; Al-Dabbagh R; Yuan Y; Tse F; Liu LW; Xenodemetropoulos T
Can J Gastroenterol Hepatol; 2016; 2016():2937678. PubMed ID: 27446835
[TBL] [Abstract][Full Text] [Related]
19. [Domperidone: off the market or freely available?].
Otten MH
Ned Tijdschr Geneeskd; 2013; 157(45):A6950. PubMed ID: 24191929
[TBL] [Abstract][Full Text] [Related]
20. Domperidone: limited benefits with significant risk for sudden cardiac death.
Hondeghem LM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
